Increased Funding For NIH Infectious Diseases Research ‘An Investment In Our Health And Our Future’

Seattle Times: Fund the National Institutes of Health to fight infectious diseases
Alan Aderem, president and director of Seattle BioMed

“…Disease research is some of the most critical and challenging work of the 21st century. Increased funding to the NIH is the single most important component to discovering new vaccines, drugs, and cures for the world’s deadliest diseases. … U.S. Reps. Rosa DeLauro, D-Conn., and Brian Higgins, D-N.Y., and U.S. Sen. Tom Harkin, D-Iowa, have introduced the Accelerating Biomedical Research Act to increase NIH funding, offsetting severe budget caps previously imposed on the agency. Harkin said, ‘It is time for us on a bipartisan basis to reverse this erosion of support for biomedical research to ensure America’s standing as a world leader in this field.’ Protecting public health is not an issue of politics. The NIH’s mission reaches across party lines. Funding it is an investment in health and our future…” (11/20).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.